Document is current
Any future updates will be listed below
-
Authors
Tsai, Hsiang-Lin
Lin, Chun-Chi
Sung, Yung-Chung
Chen, Shang-Hung
Chen, Li-Tzong
Jiang, Jeng-Kai
Wang, Jaw-Yuan http://orcid.org/0000-0002-7705-2621
-
Funding
Funding for this research was provided by:
Merck Ltd., Taipei, Taiwan, an affiliate of Merck KGaA, Darmstadt, Germany
- License Information
-
More Information
Article History
Received: 2 April 2023
Revised: 30 June 2023
Accepted: 11 July 2023
First Online: 24 July 2023
Competing interests
: The authors declare no competing interests.
: The study protocol was approved by the Institutional Review Board of Kaohsiung Medical University Hospital [KMUHIRB-G(II)-20170027], Taipei Veterans General Hospital (reference number: 2017–12-003A), Cathay General Hospital (reference number: CGH-P107013), and National Cheng Kung University Hospital (reference number: A-BR-106-045) and registered at Clinical Trials.gov. (NCT03401957). A statement that the study was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent prior to enrolment.
